Stock market data from a reputable financial data provider

EU Regulators Accuse Indian Drugmaker Alchem of Price-Fixing in Pharmaceutical Cartel

Jun 13, 2024, 09:49 AM

EU antitrust regulators have issued a formal statement of objections to Alchem International on Thursday, accusing the Indian drugmaker of participating in a pharmaceutical cartel to fix prices of a key ingredient used in drugs for stomach complaints. The allegations suggest that Alchem conspired with its rivals to manipulate the market for this essential component, leading to potentially higher costs for consumers. The formal complaint marks a significant step in the EU's ongoing efforts to combat anti-competitive practices in the pharmaceutical industry.